Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit?

Keyphrases

• Clinical Trials 100%
• Bladder Cancer 100%
• Extended Lymph Node Dissection 100%
• Multimodal Approach 50%
• Therapeutic Benefits 50%
• Cancer Patients 50%
• Survival Benefit 50%
• Adjuvant Chemotherapy 50%
• Prospective Randomized Trial 50%
• Neoadjuvant Chemotherapy 50%
• Radical Cystectomy 50%

Medicine and Dentistry

• Clinical Trial 100%
• Retroperitoneal Lymph Node Dissection 100%
• Bladder Cancer 100%
• Cystectomy 50%
• Adjuvant Chemotherapy 50%
• Neoadjuvant Chemotherapy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Bladder Cancer 100%
• Chemotherapy 50%